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Addendum to:
NF-kB Activation Represses TNF-a-Induced Autophagy
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ABstrACt
The NFkB transcription factor is an important anti-apoptotic factor, which is frequently 
deregulated in cancer cells. We have recently demonstrated that NFkB activation 
mediates the repression of autophagy in response to TNFa in three models of cancer 
cell lines. In contrast, in the absence of NFkB activation, TNFa induces macroautophagy 
(autophagy), which requires reactive oxygen species (ROS) production and participates 
in the TNFa-induced apoptotic signaling pathway. Autophagy-dependent apoptosis was 
also observed following direct addition of ROS to cells. Moreover, addition of rapamycin 
to TNFa renders these cells susceptible to the cytotoxic effect of this cytokine. These 
findings highlight the regulation of autophagy by oxidative stress and support the idea 
that repression of autophagy by NFkB may constitute a novel anti-apoptotic function of 
this transcription factor. We also bring evidence that direct stimulation of autophagy may 
represent a new therapeutic strategy for overcoming the NFkB-dependent chemoresis-
tance of cancer cells.
InACtIvAtIon oF nFkB ACtIvAtes AutoPhAgy In tnFa-treAteD Cells
NFkB	is	now	widely	recognized	as	a	major	culprit	in	cancer.1	This	transcription	factor	
activates	genes	whose	products	are	involved	in	several	tumor-promoting	signals	including	
those	 that	 favor	 cell	 survival,	 metastasis	 and	 pro-inflammatory	 responses.2	 Autophagy	
is	 another	mechanism	 involved	 in	 the	 control	 of	 cancer3	 but	 little	 is	 known	 about	 its	
modulation	by	apoptosis-regulatory	factors.
We	 investigated	 whether	 NFkB,	 which	 is	 a	 key	 regulator	 of	 apoptosis,	 modulates	
autophagy.	For	this	purpose,	we	compared	autophagic	activity	in	response	to	TNFa,	an	
efficient	 stimulator	 of	NFkB	 activation,	 in	NFkB-competent	 cells	 versus	 cells	 carrying	
a	repressor	of	NFkB	activity.	We	observed	that,	in	cell	lines	derived	from	three	types	of	
cancer	(Ewing	sarcoma,	breast	cancer	and	acute	promyelocytic	leukemia),	TNFa-induced	
NFkB	activation	causes	repression	of	autophagy.4	In	accordance	with	our	results,	 it	has	
been	 recently	 reported	 that	 inhibition	 of	 NFkB	 results	 in	 an	 enhancement	 of	 starva-
tion-induced	autophagy.5	Nevertheless,	the	mechanism	involved	in	such	NFkB-mediated	
repression	of	autophagy	remains	largely	unknown.	One	possibility	is	an	NFkB-dependent	
stimulation	 of	 the	mTOR	pathway	which	 is	 known	 to	 negatively	 regulate	 autophagy.6	
This	hypothesis	is	based	on	our	observation	that	mTOR	activity	is	induced	by	TNFa	but	
only	in	NFkB-competent	cells.4	Another	possibility	is	a	modulation	of	the	Beclin	1/Bcl-2	
balance	by	NFkB	since	Bcl-2	can	control	autophagy	by	interacting	with	Beclin	1,7	and	
NFkB	can	regulate	Bcl-2	levels.8
Interestingly,	 recent	 studies	 provided	 evidence	 that,	 in	 turn,	 NFkB	 activity	 can	 be	
modulated	by	autophagy-related	signaling.	Indeed,	NFkB	activity	is	positively	regulated	
by	an	 inhibitor	of	 the	mTOR	pathway,	TSC2.9	 Inversely,	 the	 IkB	kinase,	 an	upstream	
activator	 of	NFkB,	 was	 shown	 to	 be	 degraded	 by	 autophagy	 following	 loss	 of	Hsp90	
function10	 supporting	 that,	 in	 certain	 conditions,	 NFkB	 activity	 can	 be	 negatively	
regulated	by	autophagy.	Such	a	repression	of	NFkB	activity	by	autophagy	may	constitute	
an	amplifying	loop	of	cell	death	since	both	apoptosis	and	autophagy	are	inhibited	by	this	
transcription	factor.
regulAtIon oF AutoPhAgy By nFkB Is A reDox-sensItIve MeChAnIsM
We	and	others	have	previously	 shown	 that	 inhibition	of	NFkB	activation	 results	 in	
increased	ROS	production	in	TNFa-treated	cells.11,12	We	found	that	this	accumulation	
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of	 ROS	 is	 responsible	 of	 the	 induction	 of	 autophagy	 in	 TNFa-	
treated	cells	carrying	a	repressor	of	NFkB	activation.	In	addition,	we	
provide	evidence	that	direct	addition	of	exogenous	ROS	is	also	able	
to	induce	autophagy	in	these	cells.Consistent	with	these	observations,	
both	TNFa	 and	 ROS	 induce	 an	 increase	 in	 Beclin	 1	 expression.	
Moreover,	 rapamycin-induced	 autophagy	 is	 accompanied	 by	 ROS	
accumulation	and	lipid	peroxidation	in	yeast13	and	ROS	accumulation	
is	required	for	starvation-induced	autophagy.14	Inversely,	it	has	been	
shown	that	autophagy	can	regulate	ROS	metabolism:	Z-VAD-FMK	
(benzyloxycarbonyl-val-Ala-Asp(Ome)-fluoromethylketone),	a	broad	
spectrum	 caspase	 inhibitor	 causes	 selective	 autophagic	 degradation	
of	 catalase,	 one	 of	 the	major	 antioxidants,	 leading	 to	 intracellular	
ROS	 accumulation.15	 Also,	 in	 cells	 carrying	 a	 repressor	 of	 NFkB	
activation,	 we	 have	 observed	 that	 autophagy	 contributes	 to	 ROS	
accumulation	 induced	by	TNFa	 (data	not	 shown).	These	 findings	
demonstrate	 that	 autophagy	 and	 ROS	 metabolism	 regulate	 each	
other.
AutoPhAgy ContrIButes to the InDuCtIon oF APoPtosIs 
In tnFa-treAteD Cells
The	 involvement	 of	 autophagy	 in	 the	 apoptotic	 pathway	 has	
recently	 been	 a	 subject	 of	 debate.	Under	 certain	 stress	 conditions,	
autophagy	displays	an	anti-apoptotic	function,	whereas	recent	find-
ings	 support	 a	 pro-apoptotic	 role	 for	 this	 process.3	We	 found	 that	
knockdown	 of	 autophagy	 effectors	 with	 small	 interfering	 RNAs	
reduced	 TNFa-induced	 apoptosis	 in	 cells	 carrying	 a	 repressor	 of	
NFkB	 activation.	 A	 similar	 effect	 was	 observed	 in	 both	 NFkB-	
competent	 and	 NFkB-incompetent	 cells	 treated	 with	 exogeneous	
ROS.	These	results	indicate	that	autophagy	participates	in	the	apop-
totic	signaling	pathway	induced	by	these	compounds.
Figure 1. Stimulation of autophagy by rapamycin sensitizes Ewing sarco-
ma-derived cell lines to the cytotoxic effect of TNFa. Ewing sarcoma cells 
were transfected with green fluorescent protein (GFP) fused to LC3 protein, 
a well-established marker of autophagosomes. Twenty-four hours later, cells 
were incubated with rapamycin (400 nM) for 2 h prior treatment with or 
without TNFa (2000 units/ml). The extent of autophagy was determined by 
the analysis of GFP-LC3 distribution in cells by fluorescence microscopy. The 
percentage of cells with GFP-LC3 fluorescent dots (indicative of the redistri-
bution of GFP-LC3 into autophagosome) per total GFP-LC3 cells was scored 
16 h after the beginning of TNFa treatment (black bar). For each condition, 
cells were also subjected to Hoechst staining and the percentage of apoptotic 
cells was determined (white bar). Results shown are the mean ± SD of three 
independent experiments.
Figure 2. Proposed models for the cross-talk between autophagy and the NFkB- and ROS-activated pathways. (A) TNFa signaling pathway causes NFkB 
activation that subsequently induces several anti-apoptotic responses, including the repression of autophagy. This inhibition of autophagy is probably due to 
the NFkB-dependent inhibition of ROS accumulation. Rapamycin (an inducer of autophagy) associated with TNFa treatment sensitizes cells to TNFa-induced 
apoptosis. In turn, some observations argue for the regulation of NFkB activity by autophagy. (B) Conversely, in the situation where NFkB activity is impaired, 
TNFa upregulates the expression of the autophagy-promoting protein Beclin 1 and subsequently induces autophagy through a ROS-dependent mechanism. 
Similar responses have been observed following direct addition of ROS. In both cases, the stimulation of autophagy contributes to apoptotic signaling 
pathways. X, Y and Z represent other pro-apoptotic pathways that are stimulated in response to TNFa.
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These	 observations	 prompted	 us	 to	 investigate	 whether	 direct	
induction	 of	 autophagy	 could	 sensitize	 NFkB-competent	 cells	 to	
TNFa-induced	 apoptosis.	 For	 this	 purpose,	 cells	 were	 pretreated	
with	rapamycin	(a	well-known	activator	of	autophagy)	prior	to	addi-
tion	 of	TNFa.	 As	 shown	 in	 Figure	 1,	 although	NFkB-competent	
cells	 are	 completely	 resistant	 to	 the	 cytotoxic	 effect	 of	TNFa,	 the	
addition	 of	 rapamycin	 induced	 an	 accumulation	 of	 autophagic	
vacuoles	and	rendered	 these	cells	 susceptible	 to	 the	cytotoxic	effect	
of	 TNFa.	 Of	 note,	 TNFa	 treatment	 reduced	 the	 stimulation	 of	
autophagy	 induced	by	 rapamycin	which	 is	 in	 accordance	with	 our	
result	showing	that	NFkB	activation	by	TNFa	inhibited	autophagy.4	
It	is	worth	nothing	that	rapamycin,	when	used	alone,	did	not	increase	
the	percentage	of	apoptotic	cells.	These	results	suggest	that	autophagy	
amplifies	apoptosis	when	associated	with	a	death	receptor	signaling	
pathway.	One	possible	mechanism	involved	in	such	a	pro-apoptotic	
effect	of	autophagy	induced	by	rapamycin	may	be	mediated,	at	least	
in	part,	by	the	inhibition	of	NFkB	activity	by	this	agent.
ConClusIon
Altogether,	 these	 findings	 delineate	 the	 crosstalk	 between	
autophagy,	 NFkB	 and	 ROS	 (Fig.	 2)	 and	 raise	 the	 question	 as	 to	
whether	inducers	of	autophagy	(rapamycin	and	its	analogues)	can	be	
used	in	combination	with	anti-cancer	therapies	that	activate	NFkB	
in	order	to	improve	their	effectiveness.
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